샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777785

세계의 항생제 내성 감시 시장

Antimicrobial Resistance Surveillance
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 377 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 항생제 내성 감시 시장은 2030년까지 79억 달러에 도달

2024년에 61억 달러로 추정되는 항생제 내성 감시 세계 시장은 분석 기간인 2024-2030년 CAGR 4.6%로 성장하여 2030년에는 79억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 진단 키트는 CAGR 5.3%를 나타내고, 분석 기간 종료까지 40억 달러에 이를 것으로 예측됩니다. 진단 시스템 분야의 성장률은 분석 기간중 CAGR 4.3%로 추정됩니다.

미국 시장은 16억 달러, 중국은 CAGR 8.4%로 성장 예측

미국의 항생제 내성 감시 시장은 2024년에 16억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 17억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 8.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.8%와 3.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.7%를 나타낼 전망입니다.

세계의 항생제 내성 감시 시장 - 주요 동향과 촉진요인 정리

슈퍼버그 위협 증가는 AMR 감시를 어떻게 형성하고 있는가?

항균제 내성(AMR)은 전 세계 공중보건의 위기이며, 약제 내성 감염을 방치할 경우 2050년까지 연간 1,000만 명이 사망할 것으로 예측되고 있습니다. 다제내성(MDR) 박테리아, 곰팡이, 바이러스, 기생충 증가로 인해 전 세계적으로 견고한 AMR 감시 시스템에 대한 수요가 증가하고 있습니다. 정부, 의료 기관, 제약회사는 내성 패턴을 추적하고 완화하기 위해 조기 발견 메커니즘, 유전체 시퀀싱, 실시간 데이터 분석에 투자하고 있습니다. 세계보건기구(WHO)의 세계 항균제 내성 및 사용 감시 시스템(Global Antimicrobial Resistance and Use Surveillance System, GLASS)은 각국의 감시 접근법을 표준화하는 데 매우 중요한 역할을 해왔습니다. 그러나 많은 저자원 국가들은 데이터 수집, 검사 인프라, 진단 능력에 있어 여전히 어려움을 겪고 있으며, AMR 추적을 강화하기 위해 모바일 기반 및 AI를 활용한 혁신적인 솔루션이 필요합니다.

첨단 기술이 AMR 감시를 재정의할 수 있을까?

차세대 염기서열분석기(NGS), 머신러닝 알고리즘, 빅데이터 분석의 급속한 발전은 AMR 감시의 혁명을 가져왔으며, 내성 병원체를 보다 빠르고 정확하게 식별할 수 있게 되었습니다. AI를 활용한 예측 모델은 현재 전자의무기록(EHR)과 통합되어 AMR의 추이를 실시간으로 추적할 수 있게 되었고, 임상의가 충분한 정보를 바탕으로 치료 방침을 결정할 수 있도록 돕고 있습니다. 또한, 현장 진단 및 웨어러블 바이오센서는 임상 및 지역사회 환경 모두에서 내성 조기 발견을 향상시키고 있습니다. 클라우드 기반 플랫폼은 전 세계 데이터 공유를 가능하게 하고, 국제 협력을 촉진하며, AMR 발생에 대한 대비를 강화할 수 있습니다. AMR 데이터 관리에 블록체인 기술을 도입함으로써 투명성과 신뢰성이 향상되고, 항균제 사용량과 내성균의 진화를 정확하게 추적할 수 있게 됩니다.

AMR 감시를 전 지역으로 확대하는 데 있어서의 과제는?

이러한 발전에도 불구하고 몇 가지 장벽이 AMR 감시의 세계 확장을 가로막고 있습니다. 특히 중저소득국가(LMICs)에서는 한정된 자금, 숙련된 인력 부족, 규제 격차가 여전히 큰 문제입니다. 또한, 시판 항생제 판매, 자가 치료, 불충분한 병원 감염 관리 정책은 내성균의 조용한 확산을 조장하고 감시 활동을 더욱 복잡하게 만들고 있습니다. 가축 및 식품 공급망에서 인수공통전염병(AMR) 병원체의 존재가 증가함에 따라 인간, 동물, 환경 감시를 통합하는 보다 강력한 원헬스 접근법이 요구되고 있습니다. 전 세계적으로 AMR에 효과적으로 대응하기 위해서는 통일된 보고 기준, 실시간 데이터 접근, 정부 기관과 민간 의료기관의 협력 체계가 필수적입니다.

항균제 내성 감시 시장의 성장을 이끄는 요인은 무엇인가?

항균제 내성 감시 시장의 성장은 약제 내성 감염의 부담 증가, 유전체 시퀀싱 기술 채택 증가, 정부 주도의 감시 이니셔티브 등 여러 가지 요인에 의해 이루어질 것으로 예측됩니다. 제약업계는 동반 진단 및 내성 프로파일링 도구에 적극적으로 투자하고 있으며, 차세대 항생제 및 대체 요법 개발을 촉진하고 있습니다. AI 통합 모니터링 플랫폼, 예측 분석, 블록체인 기반 추적 시스템에 대한 수요 증가는 시장 확대를 더욱 촉진하고 있습니다. 또한, 항생제 스튜어드십 프로그램과 실시간 AMR 보고를 의무화하는 엄격한 규제 지침이 감시 인프라에 대한 투자를 촉진하고 있습니다. 정밀의료, 신속진단검사, 원헬스 프레임워크에 대한 관심이 높아짐에 따라 AMR 감시 시장을 지속적으로 견인할 것이며, 항균제 내성과의 싸움에 있어 초석으로 자리매김할 것으로 보입니다.

부문

솔루션(진단 키트, 진단 시스템, 진단 소프트웨어, 진단 서비스), 용도(임상 진단 용도, 공중위생 감시 용도, 실험실 감시 용도), 최종 용도(병원, 진료소, 기타 최종 용도)

조사 대상 기업 예

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cepheid
  • Diasorin S.P.A.
  • Liofilchem S.r.l.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Qiagen NV

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.04

Global Antimicrobial Resistance Surveillance Market to Reach US$7.9 Billion by 2030

The global market for Antimicrobial Resistance Surveillance estimated at US$6.1 Billion in the year 2024, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Diagnostic Kits, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Diagnostic Systems segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 8.4% CAGR

The Antimicrobial Resistance Surveillance market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Antimicrobial Resistance Surveillance Market - Key Trends & Drivers Summarized

How Is the Growing Threat of Superbugs Shaping AMR Surveillance?

Antimicrobial resistance (AMR) is a global public health crisis, with drug-resistant infections projected to cause 10 million deaths annually by 2050 if left unchecked. The increasing prevalence of multi-drug resistant (MDR) bacteria, fungi, viruses, and parasites has accelerated the demand for robust AMR surveillance systems worldwide. Governments, healthcare institutions, and pharmaceutical companies are investing in early detection mechanisms, genome sequencing, and real-time data analytics to track and mitigate resistance patterns. The World Health Organization’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) has been pivotal in standardizing surveillance approaches across nations. However, many low-resource countries still face challenges in data collection, laboratory infrastructure, and diagnostic capabilities, necessitating innovative mobile-based and AI-powered solutions to enhance AMR tracking.

Can Cutting-Edge Technologies Redefine AMR Surveillance?

The rapid advancements in next-generation sequencing (NGS), machine learning algorithms, and big data analytics have revolutionized AMR surveillance, allowing for faster and more precise identification of resistant pathogens. AI-driven predictive models are now being integrated with electronic health records (EHRs) to track AMR trends in real-time, helping clinicians make informed treatment decisions. Moreover, point-of-care diagnostics and wearable biosensors are improving early resistance detection in both clinical and community settings. Cloud-based platforms enable global data sharing, fostering international collaborations and reinforcing preparedness against AMR outbreaks. The introduction of blockchain technology in AMR data management is also enhancing transparency and reliability, ensuring accurate tracking of antimicrobial usage and resistance evolution.

What Are the Challenges in Expanding AMR Surveillance to All Regions?

Despite advancements, several barriers hinder the global expansion of AMR surveillance. Limited funding, lack of skilled personnel, and regulatory disparities remain major challenges, particularly in low- and middle-income countries (LMICs). Additionally, over-the-counter antibiotic sales, self-medication practices, and poor hospital infection control policies contribute to the silent spread of resistance, making surveillance efforts more complex. The growing presence of zoonotic AMR pathogens in livestock and food supply chains demands stronger One Health approaches, integrating human, animal, and environmental surveillance under a unified system. Ensuring uniform reporting standards, real-time data access, and collaboration between government agencies and private healthcare providers is imperative for tackling AMR effectively on a global scale.

What’s Fueling the Growth of the Antimicrobial Resistance Surveillance Market?

The growth in the antimicrobial resistance surveillance market is driven by several factors, including the rising burden of drug-resistant infections, increasing adoption of genomic sequencing technologies, and government-led surveillance initiatives. The pharmaceutical industry is actively investing in companion diagnostics and resistance profiling tools, fostering the development of next-generation antibiotics and alternative therapies. The increasing demand for AI-integrated surveillance platforms, predictive analytics, and blockchain-based tracking systems is further bolstering market expansion. Moreover, stringent regulatory guidelines mandating antibiotic stewardship programs and real-time AMR reporting are propelling investments in surveillance infrastructure. The growing focus on precision medicine, rapid diagnostic tests, and One Health frameworks will continue to drive the AMR surveillance market, positioning it as a cornerstone in the global fight against antimicrobial resistance.

SCOPE OF STUDY:

The report analyzes the Antimicrobial Resistance Surveillance market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Solution (Diagnostic Kits, Diagnostic Systems, Diagnostics Software, Diagnostic Services); Application (Clinical Diagnostics Application, Public Health Surveillance Application, Laboratory Surveillance Application); End-Use (Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cepheid
  • Diasorin S.P.A.
  • Liofilchem S.r.l.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Qiagen NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Antimicrobial Resistance Surveillance - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Consumer Preference for Age-Defying Grooming Solutions
    • Rising Popularity of Natural & Organic Hair Pigmentation Solutions
    • Advancements in Peptide-Based Melanin-Stimulating Compounds
    • Increasing Adoption of Herbal & Ayurvedic Anti-Graying Products
    • Expanding Male Grooming Market Fueling Demand for Beard Care Innovations
    • Technological Innovations in Long-Lasting Hair Pigmentation Solutions
    • Growing Demand for Personalized Anti-Graying Formulations
    • Influence of Social Media & Celebrity Endorsements on Product Adoption
    • Increasing Availability of Non-Invasive & Topical Anti-Graying Solutions
    • Rising Consumer Awareness About Scalp Health & Hair Follicle Longevity
    • Surging Investments in Dermatological Research for Hair Aging Reversal
    • E-commerce Expansion Driving Market Accessibility & Product Innovation
    • Emergence of Hybrid Hair Care Solutions Combining Anti-Graying & Hair Strengthening Properties
    • Sustainability & Eco-Friendly Packaging Trends Shaping Product Preferences
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Antimicrobial Resistance Surveillance Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Public Health Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Public Health Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Public Health Surveillance Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Laboratory Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Laboratory Surveillance Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Laboratory Surveillance Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • CHINA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • INDIA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Antimicrobial Resistance Surveillance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Antimicrobial Resistance Surveillance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Antimicrobial Resistance Surveillance by Solution - Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by Solution - Percentage Breakdown of Value Sales for Diagnostic Kits, Diagnostic Systems, Diagnostics Software and Diagnostic Services for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Antimicrobial Resistance Surveillance by End-Use - Other End-Uses, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Antimicrobial Resistance Surveillance by Application - Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Antimicrobial Resistance Surveillance by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics Application, Public Health Surveillance Application and Laboratory Surveillance Application for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제